ARA-290 - 10 mg - Repair

Clinical Grade Lyophilized Peptide
Dosage: 10 mg
99%+ Purity Guaranteed

Studied Benefits of ARA-290:

ARA-290 (Cibinetide) is an 11-amino-acid synthetic peptide derived from erythropoietin that selectively activates the innate repair receptor (IRR) without stimulating red-blood-cell production. Widely used in preclinical models of neuroinflammation, organ protection, and metabolic regulation, ARA-290 offers precise IRR engagement and robust cytoprotective signaling. ARA-290 (cibinetide) is a non-erythropoietic peptide that acts as an anti-inflammatory and tissue-protective agent by targeting the innate repair receptor (IRR). It is primarily researched for treating chronic neuropathic pain, particularly in patients with small fiber neuropathy and sarcoidosis, by reducing inflammation and repairing nerve tissue without affecting red blood cell production. Each vial is manufactured under ISO-certified conditions, verified at ≥99% purity by HPLC, screened for endotoxin (<0.1 EU/mg), and delivered with a full Certificate of Analysis.

Disclaimer: This content is for educational and research purposes only and is not intended as medical advice. Always conduct your own research and consult a qualified professional before use.